Last reviewed · How we verify
HCP1903
At a glance
| Generic name | HCP1903 |
|---|---|
| Sponsor | Hanmi Pharmaceutical Company Limited |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903 (PHASE1)
- Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |